HLA-DRB1等位基因特异性表达失衡修饰HLA-DRβ1氨基酸效应
该研究在48例韩国ACPA阳性RA患者和319例健康欧洲人中量化HLA-DRB1等位基因特异性表达,发现相对表达强度高度等位基因特异性,导致杂合子表达失衡。在1723例韩国ACPA阳性RA患者中,Ala-74相对表达剂量比基因组剂量更好地解释其与ACPA水平的关联。
要点
- HLA-DRB1等位基因特异性表达强度差异导致杂合子表达失衡。
- Ala-74相对表达剂量比基因组剂量更好地解释与ACPA水平的关联。
- Ala-74杂合子中无基因组变异时的表达方差与ACPA水平显著相关。
核心结论
- 将HLA-DRB1的定量与定性变化整合入单一模型有助于理解HLA-DRB1关联。
研究设计与样本
- 研究量化了48例韩国ACPA阳性RA患者和319例健康欧洲人的HLA-DRB1等位基因特异性表达。
- 在2个独立的共1723例韩国ACPA阳性RA患者集中,用多元逻辑回归建模基因组剂量或Ala-74相对表达剂量。
主要发现
- 相对表达强度高度等位基因特异性,导致HLA-DRB1杂合子等位基因表达失衡。
- Ala-74相对表达剂量比基因组剂量更好地解释HLA-DRβ1 Ala-74与ACPA水平的关联(AIC变化=-6.98)。
- Ala-74杂合子中无基因组变异时,Ala-74表达方差与ACPA水平显著相关(P=2.26×10-3)。
关键数值与推荐
- 韩国人群量化了14个HLA-DRB1等位基因,欧洲人群量化了25个。
- Ala-74相对表达剂量模型相比基因组剂量模型的AIC变化为-6.98。
- Ala-74表达方差与ACPA水平关联的P值为2.26×10-3。
临床怎么用
- 在RA遗传风险评估中可考虑HLA-DRB1等位基因表达水平而不仅基因型。
- 对ACPA阳性RA患者,Ala-74相对表达剂量可能比基因组剂量提供更精确的关联信息。
局限性
- 等位基因特异性表达量化仅在韩国RA患者和健康欧洲人中开展。
- 关联分析仅基于韩国ACPA阳性RA患者队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: HLA association fine-mapping studies have shown the effects of missense variants in HLA-DRB1 on rheumatoid arthritis (RA) susceptibility, prognosis, and autoantibody production. However, the phenotypic effects of expression changes in HLA-DRB1 remain poorly understood. Therefore, we investigated the allele-specific expression of HLA-DRB1 and its effect on an HLA-DRβ1 structure-associated trait in RA. METHODS: We quantified the allele-specific expression of each HLA-DRB1 3-field classic allele in 48 Korean RA patients with anti-citrullinated protein antibodies (ACPAs) and 319 healthy European subjects by using both RNA sequencing and HLA-DRB1 genotype data to calculate the relative expression strength of multiple HLA-DRB1 alleles (n = 14 in Koreans and n = 25 in Europeans) in each population. The known association between ACPA level and alanine at position 74 of HLA-DRβ1 in ACPA-positive RA was revisited to understand the phenotypic effect of allele-specific expression of HLA-DRB1 by modeling multivariate logistic regression with the genomic dosage or relative expression dosage of Ala-74 in 2 independent sets of 1,723 Korean RA patients with ACPA. RESULTS: The relative expression strength was highly allele-specific, causing imbalanced allelic expression in HLA-DRB1 heterozygotes. The association between HLA-DRβ1 Ala-74 and ACPA level in RA was better explained by relative expression dosage of Ala-74 than by the genomic dosage (change in Akaike's information criterion = -6.98). Moreover, the expression variance of Ala-74 in Ala-74 heterozygotes with no genomic variance of Ala-74 was significantly associated with ACPA level (P = 2.26 × 10-3 ). CONCLUSION: Our findings illustrate the advantage of integrating quantitative and qualitative changes in HLA-DRB1 into a single model for understanding HLA-DRB1 associations.
引用
- Chun S, Bang SY, Ha E, et al. Allele-Specific Quantification of HLA-DRB1 Transcripts Reveals Imbalanced Allelic Expression That Modifies the Amino Acid Effects in HLA-DRβ1. Arthritis Rheumatol. 2021. PMID: 33002286. doi:10.1002/art.41535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。